Mechanical Thrombectomy in Tandem Lesion: Effects of Extracranial Carotid Dissection Versus Atherosclerosis

Author:Quispe-Orozco, Darko   Galecio-Castillo, Milagros   Jumaa, Mouhammad   Divani, Afshin   Ribo, Marc   Abraham, Michael   Petersen, Nils   Fifi, Johanna   Guerrero, Waldo   Malik, Amer   Siegler, James   Nguyen, Thanh   Sheth, Sunil   Yoo, Albert   Linares, Guillermo   Janjua, Nazli   Tekle, Wondwossen   Abdalkader, Mohamad   Soomro, Jazba   Vivanco-Suarez, Juan   Rodriguez-Calienes, Aaron   Mokin, Maxim   Yavagal, Dileep   Hassan, Ameer   Ortega Gutierrez, Santiago   

Session Name:S6: Stroke Pathophysiology and Prediction  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S6.006  

Author Institution:University of Iowa Hospitals and Clinics, Iowa City, IA  ProMedica Stroke Network, Toledo, OH  University of New Mexico, Albuquerque, NM  Hospital vall d'Hebron, Barcelona, Spain  The University of Kansas Health System, Kansas City, KS  Yale University, New Haven, CT  Mount Sinai Hospital, New York, NY  University of South Florida College of Medicine , Tampa, FL  University of Miami Miller School of Medicine, Miami, FL  University of Chicago, Chicago, IL  Boston Medical Center, Boston, MA  University of Texas At Houston, Houston, TX  Texas Stroke Institute, Dallas, TX  Saint Louis University, Philadelphia, PA  Pomona Valley Hospital Medical Center, Montclair, CA  Valley Baptist Medical Center, Harlingen, TX  Boston Medical Center Deptartment Of Radiology, Boston, MA  Texas Stroke Institute, Plano, TX  University of South Florida, Tampa, FL  

Mechanisms of Neurodegeneration and Mini-gene Therapeutic Approach for Charcot-Marie-Tooth Disease Type 4B3

Cortical Domain Deficits Do Not Confer Risk for Cognitive Decline in Deep Brain Stimulation (DBS) for Parkinson’s Disease (PD)

Examination of Idiopathic Intracranial Hypertension in the All of Us National Data Repository: A Prospective Genetic Investigation

Outcomes of COVID-19 in Ofatumumab-treated Patients with RMS: Data from the ALITHIOS Open-label Extension Study

Author:Boer, Ibolya   Cree, Bruce   Wiendl, Heinz   Cross, Anne   Delgado, Sylvia   Habek, Mario   Khachanova, Natalia   Ward, Brian   Totolyan, Natalia   Mancione, Linda   Sullivan, Roseanne   Zielman, Ronald   Hu, Xixi   Das Gupta, Ayan   Montalban, Xavier   Winthrop, Kevin   

Session Name:P1: Multiple Sclerosis: Clinical Practice and Decision Making 1  

Topic:Multiple Sclerosis  

Program Number:P1.010  

Author Institution:Novartis Pharma AG, Basel, Switzerland  UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA  Department of Neurology with Institute of Translational Neurology, University of Münster, Muenster, Germany  Washington University School of Medicine, Saint Louis, MO  University of Miami Miller School of Medicine, Miami, FL  University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia  Pirogov Russian National Research Medical University, Moscow, Russian Federation  Infectious Diseases Division, Research Institute of the McGill University Health Centre, Montreal, QC, Canada  First Saint Petersburg State Medical University, St Petersburg , Russian Federation  Novartis Pharmaceuticals Corporation, East Hanover, NJ  Novartis Pharma B.V, Amsterdam, Netherlands  Novartis Healthcare Private Limited, Hyderabad, India  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain  School of Public Health at Oregon Health & Science University, Portland, OR